SNU Clinical Center to succeed in a phase I study.

The Seoul National University Hospital Clinical Test Center has succeeded in completion of phase I study on Pyro-arte (pyronaridine artesunate), an anti-malaria drug, under the WHO support.

The phase I study on Pryo-arte comprised of 4 tests in a large scale and performed at the SNU Hospital Clinical Test Center led by Prof. Chang In-jin of the Clinical Pharmacology Dept. The test is at a fi...